<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Borner F</submitter><funding>NCCIH NIH HHS</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>NHLBI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>e2205604</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9951388</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(6)</volume><pubmed_abstract>Specialized pro-resolving mediators (SPM), primarily produced in innate immune cells, exert crucial bioactions for resolving inflammation. Among various lipoxygenases (LOX), 15-LOX-1 is key for SPM biosynthesis, but cellular activation principles of 15-LOX-1 are unexplored. It was shown that 3-O-acetyl-11-keto-β-boswellic acid (AKBA) shifts 5-LOX regiospecificity from 5- to 12-lipoxygenation products. Here, it is demonstrated that AKBA additionally activates cellular 15-LOX-1 via an allosteric site accomplishing robust SPM formation in innate immune cells, particularly in M2 macrophages. Compared to ionophore, AKBA-induced LOX activation is Ca&lt;sup>2+&lt;/sup> - and phosphorylation-independent, with modest induction of 5-LOX products. AKBA docks into a groove between the catalytic and regulato</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>Allosteric Activation of 15-Lipoxygenase-1 by Boswellic Acid Induces the Lipid Mediator Class Switch to Promote Resolution of Inflammation.</pubmed_title><pmcid>PMC9951388</pmcid><funding_grant_id>P50 AT002776</funding_grant_id><funding_grant_id>NIH HL107887</funding_grant_id><funding_grant_id>AHA 16GRNT31000010</funding_grant_id><funding_grant_id>NIH R15GM143724</funding_grant_id><funding_grant_id>SFB1278/1 Polytarget 316213987</funding_grant_id><funding_grant_id>SFB 1127/2 ChemBioSys 239748522</funding_grant_id><funding_grant_id>NIH P50AT002776</funding_grant_id><funding_grant_id>R15 GM143724</funding_grant_id><funding_grant_id>R01 HL107887</funding_grant_id><pubmed_authors>Gilbert NC</pubmed_authors><pubmed_authors>Gerstmeier J</pubmed_authors><pubmed_authors>Gomez M</pubmed_authors><pubmed_authors>Jordan PM</pubmed_authors><pubmed_authors>Newcomer ME</pubmed_authors><pubmed_authors>Borner F</pubmed_authors><pubmed_authors>Rossi A</pubmed_authors><pubmed_authors>Pace S</pubmed_authors><pubmed_authors>Werz O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Allosteric Activation of 15-Lipoxygenase-1 by Boswellic Acid Induces the Lipid Mediator Class Switch to Promote Resolution of Inflammation.</name><description>Specialized pro-resolving mediators (SPM), primarily produced in innate immune cells, exert crucial bioactions for resolving inflammation. Among various lipoxygenases (LOX), 15-LOX-1 is key for SPM biosynthesis, but cellular activation principles of 15-LOX-1 are unexplored. It was shown that 3-O-acetyl-11-keto-β-boswellic acid (AKBA) shifts 5-LOX regiospecificity from 5- to 12-lipoxygenation products. Here, it is demonstrated that AKBA additionally activates cellular 15-LOX-1 via an allosteric site accomplishing robust SPM formation in innate immune cells, particularly in M2 macrophages. Compared to ionophore, AKBA-induced LOX activation is Ca&lt;sup>2+&lt;/sup> - and phosphorylation-independent, with modest induction of 5-LOX products. AKBA docks into a groove between the catalytic and regulato</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-05-29T05:28:03.832Z</modification><creation>2025-02-18T23:44:19.683Z</creation></dates><accession>S-EPMC9951388</accession><cross_references><pubmed>36567268</pubmed><doi>10.1002/advs.202205604</doi></cross_references></HashMap>